Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: April 2022

MissionIRNewsBreaks – Flora Growth Corp.’s (NASDAQ: FLGC) JustBrands Appointed as a Director to the US Hemp Roundtable

Flora (NASDAQ: FLGC) is a leading all-outdoor cultivator and manufacturer of global cannabis products and brands. The company today announced that its newly acquired JustBrands LLC (“JBL”), which houses leading wellness brand JustCBD, was selected as a director to the … Continue reading

Posted in Flora Growth Corp. FLGC | Leave a comment

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Begins Recruitment for Study Measuring Ketamine’s Psychedelic Effect

Cybin-sponsored study will use Kernel Flow, Kernel’s quantitative neuroimaging. Company hopes to learn more about impact ketamine has on brain activity, overall mental well-being. Study results may lead to future studies supporting CYBN’s mission to develop psychedelics into therapeutics. Cybin’s … Continue reading

Posted in Cybin Inc. CYBN | Leave a comment

MissionIRNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Appoints Former Tesla Exec to Global Manufacturing, Strategic Planning Head

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has promoted John Taylor to the role of senior vice president of Global Manufacturing and Strategic Planning; Taylor had been serving as vice president of manufacturing for Mullen since January. … Continue reading

Posted in Mullen Automotive Inc. MULN | Leave a comment

MissionIRNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Preps First Export Following Colombia’s New Export Regulations

Flora Growth (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, has announced that Colombia has completed its required regulations to allow cannabis companies operating in the country, including Flora Growth, to export THC and … Continue reading

Posted in Flora Growth Corp. FLGC | Leave a comment

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) CEO John Climaco Shares Company Highlights, Goals at 2022 Virtual Growth Conference Presented by Maxim Group LLC

The three-day event showcased CNS through corporate presentation, fireside chat, and live question and answer sessions  CNS has been granted both Orphan Drug Designation and Fast Track status from the FDA for Berubicin in 2020 and 2021, respectively CNS initiated … Continue reading

Posted in CNS Pharmaceuticals Inc. CNSP | Leave a comment

Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF), Building a House of Brands, Is Creating World-Class Standards for Environmental Impact, Social Justice, and Corporate Governance, to Navigate Increasing Commoditization in its Market Segment

Red White & Bloom, a multi-state operator in cannabis and hemp-derived product lines, has built a platform to strengthen its brands, enabling it to wade through the difficulties of increasing product commoditization The company expects to showcase the results of … Continue reading

Posted in Red White & Bloom Brands Inc. RWBYF | Leave a comment

MissionIRNewsBreaks – Nemaura Medical Inc.’s (NASDAQ: NMRD) Technologies Stand Distinct

Nemaura Medical (NASDAQ: NMRD) recently launched its MiBoKo metabolic health and wellness program, offering a distinct competitive advantage with AI-powered monitoring devices that are non-invasive, easy to wear and cost-effective. “Sensors developed by Nemaura stand apart from competitor devices that … Continue reading

Posted in MissionIRNewsBreaks, Nemaura Medical Inc. NMRD | Leave a comment

MissionIRNewsBreaks – EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQB: EVGIF) Tackling Two of the World’s Most Pressing Environmental Issues

EverGen (TSX.V: EVGN) (OTCQB: EVGIF) is a leading Canadian renewable natural gas (“RNG”) developer and one of the principal companies involved in developing Canada’s RNG infrastructure platform. The company is designed to simultaneously tackle two of the world’s most pressing … Continue reading

Posted in EverGen Infrastructure Corp. EVGIF | Leave a comment

MissionIRNewsBreaks – Pressure BioSciences Inc. (PBIO) to Host Q4 and Fiscal Year 2021 Results Teleconference, Provide Business Update

Pressure BioSciences (OTCQB: PBIO) (“PBI”), a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences and other industries, today announced plans to host a teleconference to discuss its fourth quarter and fiscal … Continue reading

Posted in Pressure BioSciences Inc. PBIO | Leave a comment

MissionIRNewsBreaks – Cybin Inc.’s (NYSE American: CYBN) (NEO: CYBN) Adelia Therapeutics Inc. Achieves New Milestone

Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics(TM),” today announced that Adelia Therapeutics, a wholly controlled subsidiary of Cybin, has achieved the milestone identified as Year 1, Q2 (iv) as contemplated by the … Continue reading

Posted in Cybin Inc. CYBN | Leave a comment